ERTS Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
ERTS Wealth Advisors's LLY Position: Q3 2026 in Review
ERTS Wealth Advisors reduced its Eli Lilly (LLY) stake by 5.7% in Q3 2026, selling an estimated $21.2K and leaving 300 shares worth $347K. The position accounts for 0.1% of the portfolio, ranked #25.
ERTS Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 12 quarters since. The position peaked at $381K in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- ERTS Wealth Advisors held 300 shares of Eli Lilly worth $347K as of Q3 2026.
- ERTS Wealth Advisors sold 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
- Eli Lilly made up 0.1% of ERTS Wealth Advisors's portfolio in Q3 2026, its #25 holding.
- ERTS Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 12 quarters since.
- ERTS Wealth Advisors's Eli Lilly position peaked at $381K in Q2 2026.
- 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on ERTS Wealth Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.